Opko Health, Inc.
OPK
$1.20
$0.010.42%
NASDAQ
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -2.12% | -3.28% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -2.12% | -3.28% | |||
| Cost of Revenue | -11.12% | -4.28% | |||
| Gross Profit | 57.72% | 3.96% | |||
| SG&A Expenses | 2.62% | -9.72% | |||
| Depreciation & Amortization | -2.44% | 0.45% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -6.69% | -5.35% | |||
| Operating Income | 19.62% | 10.77% | |||
| Income Before Tax | -213.25% | 125.49% | |||
| Income Tax Expenses | -179.11% | 240.61% | |||
| Earnings from Continuing Operations | -244.50% | 114.57% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -244.50% | 114.57% | |||
| EBIT | 19.62% | 10.77% | |||
| EBITDA | 32.93% | 16.71% | |||
| EPS Basic | -246.76% | 114.76% | |||
| Normalized Basic EPS | 13.43% | 62.45% | |||
| EPS Diluted | -248.92% | 114.76% | |||
| Normalized Diluted EPS | 13.07% | 62.61% | |||
| Average Basic Shares Outstanding | -1.50% | -1.38% | |||
| Average Diluted Shares Outstanding | -1.85% | -1.03% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||